Status:
RECRUITING
Initial Standardized Global Review in Axial Spondyloarthritis
Lead Sponsor:
Association de Recherche Clinique en Rhumatologie
Collaborating Sponsors:
RCTs
Conditions:
Axial Spondylarthritis (axSpA)
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study will be a pragmatic, cluster-randomized, controlled study with two parallel arms ( 'intervention' and 'usual care' (UC) arms) of one year duration. The study will be open-label, but center...
Eligibility Criteria
Inclusion
- Adults (but age \<80years) with a diagnosis of axial spondyloarthritis determined by the treating rheumatologist within the 12 months preceding the baseline visit, who have completed the informed consent and have the ability to complete all study activities.
Exclusion
- Patients who have already received a specific (or plan to receive in the coming 12 months) and dedicated program/global evaluation including education on the disease or treatments.
- Patients with any physical or mental condition that may affect understanding of the intervention or adherence to treatment (e.g. major depression or substance/alcohol use - might have impact on the outcomes of interest in the study).
Key Trial Info
Start Date :
May 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT07141017
Start Date
May 12 2025
End Date
May 1 2027
Last Update
August 26 2025
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Besançon - Hôpital Jean Minjoz
Besançon, France
2
CHU Bordeaux - Hôpital Pellegrin
Bordeaux, France
3
CHRU Brest - Hôpital de La Cavale Blanche
Brest, France
4
CHU Caen
Caen, France